Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy

Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy

Fahsiri Tavonvunchai, Karntida Chanwimol Department of Ophthalmology, Mettapracharak (Wat Rai Khing) Hospital, Nakhon Pathom, ThailandCorrespondence: Fahsiri Tavonvunchai, Department of Ophthalmology, Mettapracharak (Wat Rai Khing) Hospital, 52 Moo 2 Rai Khing Sam Pran, Nakhon Pathom, 73210, Thailan...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tavonvunchai F, Chanwimol K
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-06-01
Series:	International Medical Case Reports Journal
Subjects:	anti-vascular endothelial growth factor intravitreal faricimab full-thickness macular hole polypoidal choroidal vasculopathy vitreoretinal surgery
Online Access:	https://www.dovepress.com/full-thickness-macular-hole-formation-after-intravitreal-faricimab-inj-peer-reviewed-fulltext-article-IMCRJ
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Research status of clinicopathologic studies of polypoidal choroidal vasculopathy
by: LI Miaoling, et al.
Published: (2025-02-01)

Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases &ndash; The FAR-PEARL Study Report 1
by: Fong KC, et al.
Published: (2025-07-01)

Efficacy and Safety of Ophthalmic Steroids in the Management of Polypoidal Choroidal Vasculopathy: A Systematic Review
by: Adriono GA, et al.
Published: (2025-03-01)

Non-Invasive Diagnosis of Polypoidal Choroidal Vasculopathy as a Variant of the Course of Age-Related Macular Degeneration
by: I. E. Panova, et al.
Published: (2018-07-01)

Age-Related Scattered Hypofluorescent Spots as an Adverse Prognostic Factor for Polypoidal Choroidal Vasculopathy
by: Seo Hee Kim, MD, et al.
Published: (2025-09-01)

Impact of photodynamic therapy combined with Anti-VEGF vs. Anti-VEGF monotherapy on choriocapillaris vessel density in polypoidal choroidal vasculopathy
by: Po-Chin Kuo, et al.
Published: (2025-04-01)

Comparative outcomes of pars plana vitrectomy with subretinal rt-PA injection in polypoidal choroidal vasculopathy: the role of simultaneous anti-VEGF treatment
by: Lulu Chen, et al.
Published: (2025-07-01)

Functional and Anatomical Outcomes of Faricimab in Previously Treated Wet Age-Related Macular Degeneration: Systematic Review and Pooled Analysis
by: Ali Khodor, et al.
Published: (2025-07-01)

Full Thickness Macular Hole Following Intravitreal Bevacizumab for A Vascularised Pigment Epithelial Detachment
by: Neha Goel
Published: (2021-04-01)

Two-year results of switching to intravitreal administration of faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration
by: Masaaki Saito, et al.
Published: (2025-08-01)

Surgical Treatment of Previously Unclosed Macular Holes
by: R. R. Faizrakhmanov, et al.
Published: (2020-09-01)

Early Anatomical and Functional Outcomes of Faricimab in Recalcitrant Neovascular Age-Related Macular Degeneration: A Retrospective Real-World Study in an East-Asian Population
by: Yen-An Lai, et al.
Published: (2025-06-01)

Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography
by: Dorota Śpiewak, et al.
Published: (2025-06-01)

Comparative efficacy of photodynamic therapy (PDT), ranibizumab, aflibercept monotherapy, and combination therapies for polypoidal choroidal vasculopathy: a network meta-analysis of randomized controlled trials
by: Miguel A. Quiroz-Reyes, et al.
Published: (2025-07-01)

Effect of Faricimab versus Aflibercept on Hyperreflective Foci in Patients with Diabetic Macular Edema from the YOSEMITE/RHINE Trials
by: Usha Chakravarthy, FRCOphth, PhD, et al.
Published: (2025-09-01)

Pathogenetic mechanisms of macular holes: a review of recent research work
by: R. R. Fayzrakhmanov, et al.
Published: (2023-07-01)

Analysis of cytokine profiles in aqueous humor based on optical coherence tomography in pachychoroid spectrum diseases
by: Caiyun Zhang, et al.
Published: (2025-07-01)

Short-term real-world effectiveness of faricimab on macular edema due to retinal vein occlusion
by: Toshiaki Hirakata, et al.
Published: (2025-07-01)

Intravitreal Ranibizumab for Treatment of Posttraumatic Choroidal Neovascularization: a Case Report
by: A. N. Kulikov, et al.
Published: (2021-10-01)

A delphi consensus study for treatment of full-thickness macular hole in Taiwan
by: Meng-Ju Tsai, et al.
Published: (2025-07-01)

Risk factors and Response of Branch Retinal Vein Occlusion induced Macular Edema to intravitreal injections of Triamcinolone and Bevacizumab
by: Singhai Prakhar, et al.
Published: (2017-07-01)

Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study
by: Marco Lupidi, et al.
Published: (2025-07-01)

Safety Evaluation of Bilateral Same-Day Intravitreal Injection of Faricimab
by: Michael D. Karampelas, et al.
Published: (2025-06-01)

Real-world outcomes of a loading phase with intravitreal faricimab in refractory Neovascular Age-Related Macular Degeneration (nAMD) patients
by: Xu Yufeng, et al.
Published: (2025-07-01)

Long-term optical coherence tomography changes and visual outcomes after vitrectomy for epiretinal proliferation: lamellar holes and full-thickness macular holes
by: Tarin T. Tanji, et al.
Published: (2025-07-01)

Pachychoroid Spectrum Disorders: A Review of Clinical Features and Management
by: Devesh Kumawat, et al.
Published: (2019-07-01)

Short-term outcomes of faricimab and aflibercept 8 mg in diabetic macular edema
by: Carlo Maccauro, et al.
Published: (2025-07-01)

The effect of intravitreal administration of bevacizumab on macular edema and visual acuity in age-related macular degeneration with subfoveolar choroidal neovascularisation
by: Ristić Dragana, et al.
Published: (2013-01-01)

Revisiting the Role of Intravitreal Triamcinolone in Diabetic Macular Edema: 12-Month Outcomes after Bevacizumab Failure
by: Sukhum Silpa-archa, et al.
Published: (2025-06-01)

Macular hole surgery in times of the COVID-19 pandemic
by: Nathalie Bleidißel, et al.
Published: (2025-04-01)

Efficacy of a simple intravitreal perfluoropropane injection in treating unclosed idiopathic macular holes following vitrectomy
by: Zexia Dou, et al.
Published: (2025-02-01)

Surgical treatment of recurrent macular hole
by: D.O. Shkvorchenko, et al.
Published: (2023-11-01)

Comparison of Early Treatment Outcomes for Large Macular Hole Using Various Surgical Techniques
by: D. V. Petrachkov, et al.
Published: (2021-10-01)

Effect of vascular endothelial growth factor inhibitors on choroid in patients with macular choroid neovascular membrane and degenerative myopia . Preliminary report
by: V. A. Solomin, et al.
Published: (2014-07-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Glucocorticosteroids and Postradiation Macular Edema: Rationale for Choice of Therapy and Efficacy of Use
by: I. E. Panova, et al.
Published: (2024-10-01)

Preferences of Hospital Pharmacists for the Different Attributes of Intravitreal Treatments for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Spain: The SEEKING Study
by: José Luis Poveda, et al.
Published: (2025-05-01)

Polypoidal Choroidal Vasculopathy in Congolese Patients
by: Nelly N. Kabedi, et al.
Published: (2020-01-01)

Time-in-Range Analysis of Responses after Intravitreal Dexamethasone Therapy in Eyes with Diabetic Macular Edema
by: Igor Kozak, MD, PhD, et al.
Published: (2025-09-01)

Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration
by: Onur Polat, et al.
Published: (2017-08-01)